Morgan Stanley’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.65M | Buy |
1,336,293
+445,364
| +50% | +$1.99M | ﹤0.01% | 4049 |
|
|
2025
Q4 | $3.36M | Sell |
890,929
-163,862
| -16% | -$318K | ﹤0.01% | 4464 |
|
|
2025
Q3 | $1.7M | Sell |
1,054,791
-29,687
| -3% | -$52.9K | ﹤0.01% | 4878 |
|
|
2025
Q2 | $2.38M | Buy |
1,084,478
+1,018,028
| +1,532% | +$1.56M | ﹤0.01% | 4588 |
|
|
2025
Q1 | $71.8K | Buy |
66,450
+50,672
| +321% | +$60.2K | ﹤0.01% | 6152 |
|
|
2024
Q4 | $16.4K | Sell |
15,778
-1,657
| -10% | -$1.89K | ﹤0.01% | 6632 |
|
|
2024
Q3 | $21.8K | Buy |
17,435
+14,138
| +429% | +$17.3K | ﹤0.01% | 6481 |
|
|
2024
Q2 | $3.92K | Buy |
3,297
+1,877
| +132% | +$2.55K | ﹤0.01% | 6916 |
|
|
2024
Q1 | $1.43K | Sell |
1,420
-1,420
| -50% | -$1.19K | ﹤0.01% | 7126 |
|
|
2023
Q4 | $3.01K | Buy |
2,840
+420
| +17% | +$455 | ﹤0.01% | 7086 |
|
|
2023
Q3 | $3.97K | Sell |
2,420
-6,000
| -71% | -$9.46K | ﹤0.01% | 6966 |
|
|
2023
Q2 | $13.2K | Buy |
8,420
+3,020
| +56% | +$4.85K | ﹤0.01% | 6706 |
|
|
2023
Q1 | $7.72K | Sell |
5,400
-50,158
| -90% | -$124K | ﹤0.01% | 6958 |
|
|
2022
Q4 | $131K | Buy |
55,558
+2,133
| +4% | +$5.98K | ﹤0.01% | 5859 |
|
|
2022
Q3 | $108K | Sell |
53,425
-38,046
| -42% | -$105K | ﹤0.01% | 6040 |
|
|
2022
Q2 | $204K | Buy |
91,471
+172
| +0.2% | +$504 | ﹤0.01% | 5882 |
|
|
2022
Q1 | $610K | Sell |
91,299
-32,835
| -26% | -$192K | ﹤0.01% | 5290 |
|
|
2021
Q4 | $686K | Sell |
124,134
-60,734
| -33% | -$460K | ﹤0.01% | 5351 |
|
|
2021
Q3 | $1.69M | Buy |
184,868
+169,369
| +1,093% | +$1.57M | ﹤0.01% | 4702 |
|
|
2021
Q2 | $172K | Buy |
15,499
+11,599
| +297% | +$113K | ﹤0.01% | 6087 |
|
|
2021
Q1 | $33K | Buy |
3,900
+2,250
| +136% | +$18.4K | ﹤0.01% | 6548 |
|
|
2020
Q4 | $10K | Sell |
1,650
-1,185
| -42% | -$4.74K | ﹤0.01% | 6638 |
|
|
2020
Q3 | $7K | Sell |
2,835
-230
| -8% | -$630 | ﹤0.01% | 6377 |
|
|
2020
Q2 | $9K | Sell |
3,065
-31,831
| -91% | -$86.3K | ﹤0.01% | 6190 |
|
|
2020
Q1 | $60K | Buy |
34,896
+33,186
| +1,941% | +$85.4K | ﹤0.01% | 5399 |
|
|
2019
Q4 | $7K | Buy |
1,710
+506
| +42% | +$2.72K | ﹤0.01% | 6349 |
|
|
2019
Q3 | $7K | Buy |
1,204
+299
| +33% | +$2.2K | ﹤0.01% | 6303 |
|
|
2019
Q2 | $5K | Buy |
905
+311
| +52% | +$11K | ﹤0.01% | 6318 |
|
|
2019
Q1 | $31K | Buy |
594
+27
| +5% | +$1.88K | ﹤0.01% | 5868 |
|
|
2018
Q4 | $34K | Buy |
567
+38
| +7% | +$2.94K | ﹤0.01% | 5868 |
|
|
2018
Q3 | $32K | Hold |
529
| – | – | ﹤0.01% | 6008 |
|
|
2018
Q2 | $90K | Hold |
529
| – | – | ﹤0.01% | 5765 |
|
|
2018
Q1 | $91K | Buy |
529
+504
| +2,016% | +$144K | ﹤0.01% | 5729 |
|
|
2017
Q4 | $10K | Buy |
25
+3
| +14% | +$1.45K | ﹤0.01% | 6218 |
|
|
2017
Q3 | $12K | Sell |
22
-32
| -59% | -$21.1K | ﹤0.01% | 6135 |
|
|
2017
Q2 | $47K | Buy |
54
+5
| +10% | +$4.35K | ﹤0.01% | 5877 |
|
|
2017
Q1 | $45K | Buy |
49
+5
| +11% | +$8.28K | ﹤0.01% | 5857 |
|
|
2016
Q4 | $128K | Buy |
+44
| New | +$256K | ﹤0.01% | 5496 |
|
Other funds holding SLS
VCM
VPM
VFT
DI